Skip to main content

ACP Journal Club. Review: In patients having PCI, high-dose clopidogrel reduces major cardiac events vs standard-dose clopidogrel.

Publication ,  Journal Article
Rymer, JA; Newby, LK
Published in: Ann Intern Med
May 19, 2015

Duke Scholars

Published In

Ann Intern Med

DOI

EISSN

1539-3704

Publication Date

May 19, 2015

Volume

162

Issue

10

Start / End Page

JC13

Location

United States

Related Subject Headings

  • Ticlopidine
  • Platelet Aggregation Inhibitors
  • Percutaneous Coronary Intervention
  • Myocardial Infarction
  • Humans
  • General & Internal Medicine
  • 3202 Clinical sciences
  • 11 Medical and Health Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Rymer, J. A., & Newby, L. K. (2015). ACP Journal Club. Review: In patients having PCI, high-dose clopidogrel reduces major cardiac events vs standard-dose clopidogrel. Ann Intern Med, 162(10), JC13. https://doi.org/10.7326/ACPJC-2015-162-10-013
Rymer, Jennifer A., and L Kristin Newby. “ACP Journal Club. Review: In patients having PCI, high-dose clopidogrel reduces major cardiac events vs standard-dose clopidogrel.Ann Intern Med 162, no. 10 (May 19, 2015): JC13. https://doi.org/10.7326/ACPJC-2015-162-10-013.
Rymer, Jennifer A., and L. Kristin Newby. “ACP Journal Club. Review: In patients having PCI, high-dose clopidogrel reduces major cardiac events vs standard-dose clopidogrel.Ann Intern Med, vol. 162, no. 10, May 2015, p. JC13. Pubmed, doi:10.7326/ACPJC-2015-162-10-013.

Published In

Ann Intern Med

DOI

EISSN

1539-3704

Publication Date

May 19, 2015

Volume

162

Issue

10

Start / End Page

JC13

Location

United States

Related Subject Headings

  • Ticlopidine
  • Platelet Aggregation Inhibitors
  • Percutaneous Coronary Intervention
  • Myocardial Infarction
  • Humans
  • General & Internal Medicine
  • 3202 Clinical sciences
  • 11 Medical and Health Sciences